MHS Related Analyst Ratings
-
UBS on Healthcare Distribution - PBMs: Implications from SXCI/CHSI Deal
-
Jefferies Reiterates a 'Buy' on Express Scripts (ESRX); FTC Review Extension Was Expected; Closing Target Specificity A Bullish Sign
-
Macquarie Downgrades Medco Health Solutions (MHS) to Neutral
-
Davenport Cuts Medco Health Solutions (MHS) to Reduce
-
JMP Cuts Medco (MHS) to Market Perform
-
Jefferies Maintains a 'Buy' on Express Scripts (ESRX); Incurs High Q4 Expenses As Its Preps For MHS Integration
-
Morgan Stanley Downgrades Medco Health Solutions (MHS) to Equalweight
-
UBS Maintains a 'Buy' on Medco Health Solutions (MHS); Read-through From UNH; Raise ‘13 EPS
-
UBS Maintains a 'Neutral' on CVS Caremark (CVS); Raising ‘13 EPS for Generics/PBM Mojo
-
UBS Maintains a 'Buy' on AmerisourceBergen (ABC); Lower F2013-14 EPS For Generics + Medco
-
UBS Maintains a 'Buy' on CVS Caremark (CVS); Post-Call: Plenty of Positive Datapoints
-
Deutsche Bank Raises Medco (MHS) to Buy; Says Overhangs Removed
-
Jefferies Cuts Price Target on Walgreen (WAG), Encourges a Settlement with Express Scripts (ESRX)
-
Jefferies Comments on Express Scripts (ESRX), Great Long-Term Pick for Investors
-
UPDATE - Barclays Downgraded Walgreen (WAG) to Underweight; Cutting Estimates & PT
-
Q2 Preview: CVS (CVS) Looking to PBM to Continue Strong Results
-
Leerink Swann Downgrades Medco Health Solutions (MHS) to Market Perform; Changing Landscape
-
UBS Maintains a 'Buy' on Medco Health Solutions (MHS); FTC Review Prep: Market Share Analysis
-
FBR Capital Downgrades Medco Health Solutions (MHS) to Market Perform
-
Argus Downgrades Medco Health Solutions (MHS) to Hold
-
BMO Capital Downgrades Medco Health Solutions (MHS) to Market Perform
-
Bernstein Downgrades Medco Health Solutions (MHS) to Market Perform
-
Stifel Nicolaus Downgrades Medco Health Solutions (MHS) to Hold
-
Citadel Securities Upgrades Express Scripts (ESRX) to Neutral; More Balanced Risk-Reward
-
Citadel Securities Upgrades Medco Health Solutions (MHS) to Neutral; More Balanced Risk-Reward
-
Barclays Maintains an 'Overweight' on Medco Health Solutions (MHS); Updating Model Assumptions
-
UBS Maintains a 'Buy' on Medco Health Solutions (MHS); Let's Get This Over With (United Health)
-
Credit Suisse Reiterates an 'Outperform' on Medco Health Solutions (MHS); Implications of FEP Loss; Lowering Estimates and Target Price
-
FBR Capital Maintains an 'Outperform' on Medco Health (MHS); Removes as Top Pick
-
AmerisourceBergen (ABC) Seen Taking a Hit from MedcoHealth Contract Loss
-
Cowen Starts Healthcare Stocks: ESRX, MHS, MDRX, CAH, MCK, ABC at Outperform, CERN, SXCI, QSII at Neutral
-
FBR Capital Maintains an 'Outperform/Top Pick' on Medco Health (MHS); Starts the Year Off Right, but FEP and United Overhangs Still Remain
-
FBR Capital on Healthcare Services 1Q11 Earnings Preview
-
Citi Adds Medco Health (MHS) to 'Top Picks Live' List, Raises Target to $77
-
Deutsche Bank Downgrades Medco Health Solutions (MHS) to 'Hold' Given Uncertainty Post CalPERS
-
Credit Suisse Sees Value Creation From UnitedHealth's (UNH) PBM
-
FBR Capital reiterates an 'Outperform/Top Pick' on Medco Health Solutions (MHS); 2012 Remains the Key
-
Barclays on U.S. Health Care Distribution & Technology: PBMs - 'Pass Through' Transparent Pricing Further Explored at FEP: Migration Risk for 2012?
-
UBS on U.S. Healthcare Distribution: 2011 Outlook and Quarterly Preview
-
UBS Maintains a 'Buy' on Cardinal Health (CAH); Still The Cheapest Stock In Our Universe
-
FBR Capital: Healthcare Services 2011 Outlook
-
UBS Maintains a 'Buy' on Medco Health Solutions (MHS), Additional Takeaways from Analyst Day
-
FBR Capital Maintains an 'Outperform' on Medco Health Solutions (MHS); Investor Day Sheds Light On Long Term Plans
-
Caris & Co. Upgrades Medco Health Solutions (MHS) to Buy
-
FBR Capital Maintains an 'Outperform/Top Pick' on Medco Health Solutions (MHS); Focus Shifting to 2012
-
RBC Starts Express Scripts (ESRX), Medco (MHS) at Outperform, CVS (CVS) at Sector Perform
-
UPDATE - UBS Downgrades Omnicare (OCR) to Neutral; Moving To The Sidelines Post +25% Rally
-
Goldman Sachs removed MedcoHealth (MHS) from Conviction Buy List
-
FBR Capital Launching Coverage of Pharmacy Benefit Management Services: Trends Favor the Prepared
-
Avondale Partners Initiates Coverage on Retail (Drugs) Stocks CVS & MHS
Back to MHS Stock Lookup
